1. Home
  2. XBP vs NSRX Comparison

XBP vs NSRX Comparison

Compare XBP & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBP Europe Holdings Inc.

XBP

XBP Europe Holdings Inc.

N/A

Current Price

$3.20

Market Cap

41.3M

ML Signal

N/A

Logo Nasus Pharma Ltd. Ordinary Shares

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$3.51

Market Cap

38.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
XBP
NSRX
Founded
N/A
2019
Country
United States
Israel
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.3M
38.9M
IPO Year
2021
2024

Fundamental Metrics

Financial Performance
Metric
XBP
NSRX
Price
$3.20
$3.51
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$5.00
★ $19.67
AVG Volume (30 Days)
★ 26.0K
14.2K
Earning Date
05-15-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 183.67
N/A
EPS
N/A
★ N/A
Revenue
★ $872,690,000.00
N/A
Revenue This Year
$2.59
N/A
Revenue Next Year
$5.75
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.41
$1.98
52 Week High
$8.55
$9.50

Technical Indicators

Market Signals
Indicator
XBP
NSRX
Relative Strength Index (RSI) 55.82 50.48
Support Level $2.10 $2.97
Resistance Level $3.87 $3.60
Average True Range (ATR) 0.28 0.27
MACD 0.03 -0.02
Stochastic Oscillator 42.48 68.73

Price Performance

Historical Comparison
XBP
NSRX

About XBP XBP Europe Holdings Inc.

XBP Global Holdings Inc is a multinational technology and services company that drives intelligent workflows for organizations. Through its proprietary platforms, agentic AI-driven automation, and domain expertise across industries and the public and private sectors, the firm enables its clients to entrust their digital transformations and workflows. The segments of the company are Applied Workflow Automation and Technology. The Applied Workflow Automation segment generates maximum revenue and provides services powered by intelligent, AI-enabled workflows that generate outcomes for client's systems, while the Technology segment focuses on the sale of recurring and perpetual software licenses, software maintenance and professional services, as well as hardware solutions and maintenance.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: